According to the latest information from the Hong Kong Stock Exchange, on October 14, a shareholder of JACOBIO-B (01167) transferred shares from HSBC Bank (Hong Kong Shanghai) to CITIC Lyon Securities. The transfer involved a market value of HK$314 million, representing 5.04% of the company's shares.

JACOBIO-B released its 2025 interim results, showing the group achieved revenue of RMB 45.664 million during the period, compared to zero revenue in the same period last year. The loss attributable to owners was RMB 58.994 million, narrowing by 65.1% year-on-year.

According to the announcement, the revenue growth was primarily attributed to milestone payments from the Eli Lilly licensing agreement.